At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 64 enrolled
Drug / intervention
KNEE JOINT INFILTRATION WITH HYALURONIC ACID WITH SORBITOL SYNOLIS VAdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Effectiveness of Hyaluronic Acid and Sorbitol With Overuse Knee Pain in Sportsmen
In Brief
A Phase 3 clinical trial evaluating KNEE JOINT INFILTRATION WITH HYALURONIC ACID WITH SORBITOL SYNOLIS VA for Overuse Injury and Body Mass Index in Athletes. Completed, enrolled 64 participants across 1 site.
Detailed Summary
Sports activity represents part of day living people, a knee pain originated by high demand joint activity could represent a limitation to continue sports. The aim of this clinical trial is demonstrate the effects of hyaluronic acid in sportsmen with knee pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOveruse Injury, Body Mass Index in Athletes
CountriesMexico
Collaborators--
Timeline
Phase 3CompletedFinished
2023202420252026
First PostedJul 2022
Enrollment StartFeb 2023
Primary CompletionOct 2024
Study CompletionApr 2025
TodayJul 2026
First PostedJul 8, 2022
Enrollment StartFeb 1, 2023
Primary CompletionOct 30, 2024
Study CompletionApr 30, 2025
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.0 years ago
Interventions
KNEE JOINT INFILTRATION WITH HYALURONIC ACID WITH SORBITOL SYNOLIS VAdrug
KNEE INFILTRATION WITH HYALURONIC ACID WITH SORBITOL IN SPORTSMEN